Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T Gunning

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Oncotarget|August 29, 2015
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activationMohini Singh, Neha Garg, Chitra Venugopal, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Nature Communications|June 9, 2019
Structural and functional consequences of the STAT5B<sup>N642H</sup> driver mutationElvin D de Araujo, Fettah Erdogan, Heidi A Neubauer, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Cancer Cell|January 16, 2019
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor DiseaseLindsay Kosack, Bettina Wingelhofer, Alexandra Popa, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Haematologica|May 25, 2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemiaBarbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
EMBO Molecular Medicine|November 7, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Oncotarget|August 29, 2015
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activationMohini Singh, Neha Garg, Chitra Venugopal, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Nature Communications|June 9, 2019
Structural and functional consequences of the STAT5B<sup>N642H</sup> driver mutationElvin D de Araujo, Fettah Erdogan, Heidi A Neubauer, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Cancer Cell|January 16, 2019
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor DiseaseLindsay Kosack, Bettina Wingelhofer, Alexandra Popa, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Haematologica|May 25, 2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemiaBarbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
EMBO Molecular Medicine|November 7, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.
Pageof 10